Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.65
Bid: 0.00
Ask: 93.75
Change: 0.00 (0.00%)
Spread: 2.05 (2.236%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 91.65
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - PHP (Replacement)

25 Feb 2019 15:56

RNS Number : 0549R
Canaccord Genuity Limited
25 February 2019
 

PLEASE NOTE THAT THIS DISCLOSURE REPLACES RNS 0193R ON 25 FEBRUARY AT 11.12AM

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Primary Health Properties Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

22 February 2019

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 12.5P

 

 

 

Buy

Sell

 

32,216

190,108

 

 

 

120p

120.8p

 

 

119.6p

119.51p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

25 February 2019

Contact name:

Sam Holland

Telephone number:

020 7523 8337

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERDMGZZKKKGLZM
Date   Source Headline
22nd Aug 20222:11 pmRNSHolding(s) in Company
15th Aug 20224:14 pmRNSApplication for Listing and Total Voting Rights
5th Aug 20225:00 pmRNSConvertible Bond Adjustment
27th Jul 20227:00 amRNSInterim Results
25th Jul 20227:00 amRNSAcquisition
14th Jul 202210:47 amRNSScrip dividend reference price
11th Jul 20227:00 amRNSInvestor Presentation
7th Jul 20227:00 amRNSDisposal of 13 assets for £27.7 million
30th Jun 20227:00 amRNSNotice of Interim Results
30th Jun 20227:00 amRNSDividend Declaration
28th Jun 20224:57 pmRNSDirector/PDMR Shareholding
28th Jun 20224:53 pmRNSDirector/PDMR Shareholding
24th May 20222:33 pmRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
24th May 20221:25 pmRNSDirector/PDMR Shareholding
16th May 202211:00 amRNSApplication for listing and total voting rights
3rd May 20225:35 pmRNSDirector Declaration
27th Apr 20224:51 pmRNSResult of AGM
27th Apr 20227:00 amRNSQ1 2022 Trading Update
20th Apr 20224:44 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSAcquisition
11th Apr 20227:00 amRNSFirst Net Zero Carbon ("NZC") Direct Development
7th Apr 20225:30 pmRNSDirector/PDMR Shareholding
7th Apr 20225:30 pmRNSDirector/PDMR Shareholding
7th Apr 202211:20 amRNSScrip dividend reference price
7th Apr 202211:20 amRNSNotice of Interim Dividend - Replacement
1st Apr 20227:00 amRNSAcquisition
24th Mar 20227:00 amRNSDividend Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:15 amRNSAnnual Financial Report
7th Mar 20225:30 pmRNSDirector/PDMR Shareholding
7th Mar 20225:30 pmRNSDirector/PDMR Shareholding
4th Mar 20225:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20227:01 amEQSEdison Investment Research Limited: Primary Health Properties (PHP): Continuing strong DPS growth well supported
23rd Feb 20223:46 pmRNSDirector/PDMR Shareholding
22nd Feb 202212:22 pmRNSDirector/PDMR Shareholding
21st Feb 202211:51 amRNSApplication for listing
16th Feb 20227:01 amRNSLaunch of Net Zero Carbon (“NZC”) Framework
16th Feb 20227:00 amRNSPreliminary Results
15th Feb 20224:47 pmRNSHolding(s) in Company
14th Feb 202210:52 amRNSHolding(s) in Company
10th Feb 202211:12 amRNSHolding(s) in Company
9th Feb 20223:10 pmRNSDirector/PDMR Shareholding
9th Feb 20223:10 pmRNSDirector/PDMR Shareholding
20th Jan 202211:41 amRNSScrip dividend reference price
19th Jan 20227:00 amRNSNotice of Preliminary Results
18th Jan 20223:24 pmRNSHolding(s) in Company
13th Jan 20224:58 pmRNSHolding(s) in Company
11th Jan 202211:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.